216 related articles for article (PubMed ID: 33163922)
1. Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second-line chemotherapy.
Yamamoto A; Nakai Y; Oka T; Kanaki T; Yamamoto Y; Nagahara A; Nakayama M; Kakimoto KI; Nishimura K
IJU Case Rep; 2020 Nov; 3(6):270-273. PubMed ID: 33163922
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival of a patient with refractory advanced adrenocortical carcinoma after combination chemotherapy with paclitaxel and carboplatin plus mitotane.
Kobayakawa Y; Hamamoto S; Kamisawa H; Okada S; Taguchi K; Naiki T; Okada A; Tozawa K; Yasui T
IJU Case Rep; 2022 Jul; 5(4):288-292. PubMed ID: 35795129
[TBL] [Abstract][Full Text] [Related]
3. [Advanced Adrenocortical Carcinoma with Vena Caval Tumor Thrombus Treated with Extended Surgery and Subsequent Chemotherapy].
Nakajima S; Narita S; Sato H; Igarashi R; Nara T; Kanda S; Numakura K; Saito M; Inoue T; Satoh S; Yamamoto H; Yamamoto Y; Habuchi T
Hinyokika Kiyo; 2019 Oct; 65(10):397-402. PubMed ID: 31697884
[TBL] [Abstract][Full Text] [Related]
4. Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy.
Grisanti S; Cosentini D; Laganà M; Morandi A; Lazzari B; Ferrari L; Volta AD; Ambrosini R; Ferrari VD; Sigala S; Berruti A
Front Endocrinol (Lausanne); 2021; 12():624102. PubMed ID: 33716976
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study.
Sperone P; Ferrero A; Daffara F; Priola A; Zaggia B; Volante M; Santini D; Vincenzi B; Badalamenti G; Intrivici C; Del Buono S; De Francia S; Kalomirakis E; Ratti R; Angeli A; Dogliotti L; Papotti M; Terzolo M; Berruti A
Endocr Relat Cancer; 2010 Jun; 17(2):445-53. PubMed ID: 20410174
[TBL] [Abstract][Full Text] [Related]
6. [A Case Report of a Patient with Metastatic Adrenocortical Carcinoma who Received the Combination Etoposide, Doxorubicin, Cisplatin, and Mitotane Therapy and Achieved Remission].
Ueda S; Nakane K; Namiki S; Takeuchi Y; Kawase M; Takeuchi S; Kawase K; Nakai C; Kato D; Takai M; Iinuma K; Tsuchiya T; Miyazaki T; Koie T
Hinyokika Kiyo; 2022 May; 68(5):139-143. PubMed ID: 35748231
[TBL] [Abstract][Full Text] [Related]
7. Unusual Techniques for Preserving Surgical and Oncologic Safety in Hepatectomy of Advanced Adrenal Malignancy with Vena Cava and Liver Invasion.
Lee JM; Lee KW; Hong SK; Yoon KC; Cho JH; Yi NJ; Suh KS
Ann Surg Oncol; 2018 Oct; 25(11):3324-3325. PubMed ID: 30019302
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors.
Henning JEK; Deutschbein T; Altieri B; Steinhauer S; Kircher S; Sbiera S; Wild V; Schlötelburg W; Kroiss M; Perotti P; Rosenwald A; Berruti A; Fassnacht M; Ronchi CL
J Clin Endocrinol Metab; 2017 Nov; 102(11):4323-4332. PubMed ID: 29092062
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical carcinoma: current treatment options.
De Filpo G; Mannelli M; Canu L
Curr Opin Oncol; 2021 Jan; 33(1):16-22. PubMed ID: 33186181
[TBL] [Abstract][Full Text] [Related]
10. Adrenocortical Carcinoma with a Renal Vein Thrombus Extending to the Inferior Vena Cava Successfully Resected with the Left Kidney and Distal Pancreatectomy: A Case Report.
Miyata T; Sannomiya Y; Nagayama T; Kin R; Nishiki H; Hashimoto A; Kaida D; Fujita H; Ueda N; Takamura H
Case Rep Oncol; 2024; 17(1):377-385. PubMed ID: 38415268
[TBL] [Abstract][Full Text] [Related]
11. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
12. Advanced Adrenocortical Carcinoma - What to do when First-Line Therapy Fails?
Megerle F; Kroiss M; Hahner S; Fassnacht M
Exp Clin Endocrinol Diabetes; 2019 Feb; 127(2-03):109-116. PubMed ID: 30469158
[TBL] [Abstract][Full Text] [Related]
13. Massive adrenocortical carcinoma presenting as peripheral edema: a case report.
Goodkin DA
J Med Case Rep; 2022 Jun; 16(1):249. PubMed ID: 35725572
[TBL] [Abstract][Full Text] [Related]
14. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Adrenocortical Carcinoma Successfully Treated with Multimodal Therapy].
Bando S; Ishii G; Yamada H; Kimura T; Furuta N; Egawa S
Hinyokika Kiyo; 2016 Jan; 62(1):15-9. PubMed ID: 26932330
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy in advanced adrenocortical carcinoma.
Fassnacht M; Terzolo M; Allolio B; Baudin E; Haak H; Berruti A; Welin S; Schade-Brittinger C; Lacroix A; Jarzab B; Sorbye H; Torpy DJ; Stepan V; Schteingart DE; Arlt W; Kroiss M; Leboulleux S; Sperone P; Sundin A; Hermsen I; Hahner S; Willenberg HS; Tabarin A; Quinkler M; de la Fouchardière C; Schlumberger M; Mantero F; Weismann D; Beuschlein F; Gelderblom H; Wilmink H; Sender M; Edgerly M; Kenn W; Fojo T; Müller HH; Skogseid B;
N Engl J Med; 2012 Jun; 366(23):2189-97. PubMed ID: 22551107
[TBL] [Abstract][Full Text] [Related]
17. Favorable response of metastatic adrenocortical carcinoma to etoposide, adriamycin and cisplatin (EAP) chemotherapy. Report of two cases.
Berruti A; Terzolo M; Paccotti P; Veglio F; Pia A; Dogliotti L; Angeli A
Tumori; 1992 Oct; 78(5):345-8. PubMed ID: 1494808
[TBL] [Abstract][Full Text] [Related]
18. [Three Cases of Advanced or Recurrent Adrenocortical Carcinoma Patients Treated with Etoposide, Doxorubicin and Cisplatin plus Mitotane].
Sasaki S
Gan To Kagaku Ryoho; 2018 Jan; 45(1):67-70. PubMed ID: 29362311
[TBL] [Abstract][Full Text] [Related]
19. Durable response to pembrolizumab in microsatellite instability-high advanced adrenocortical carcinoma.
Senda M; Hashimoto K; Shindo T; Kobayashi K; Tanaka T; Masumori N
IJU Case Rep; 2023 Nov; 6(6):382-385. PubMed ID: 37928286
[TBL] [Abstract][Full Text] [Related]
20. Multi-Target Approach to Metastatic Adrenal Cell Carcinoma.
Wahab NA; Zainudin S; AbAziz A; Mustafa N; Sukor N; Kamaruddin NA
Arch Iran Med; 2016 Sep; 19(9):671-3. PubMed ID: 27631184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
